Journal article 782 views 118 downloads
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes
Frontiers in Public Health, Volume: 8
Swansea University Authors: Olivia McCarthy, Rachel Deere, Jason Pitt, Benjamin Wellman, Steve Bain , Richard Bracken
-
PDF | Version of Record
© 2021 McCarthy, Deere, Eckstein, Pitt, Wellman, Bain, Moser and Bracken. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)
Download (535.76KB)
DOI (Published version): 10.3389/fpubh.2020.568832
Abstract
Aim: To explore the influence of clinical exercise trial participation on glycaemia and insulin therapy use in adults with type 1 diabetes (T1D). Research Design and Methods: This study involved a secondary analysis of data collected from 16 individuals with T1D who completed a randomized clinical t...
Published in: | Frontiers in Public Health |
---|---|
ISSN: | 2296-2565 |
Published: |
Frontiers Media SA
2021
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa55783 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2020-11-30T09:35:57Z |
---|---|
last_indexed |
2021-02-03T04:11:05Z |
id |
cronfa55783 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2021-02-02T09:14:13.5451006</datestamp><bib-version>v2</bib-version><id>55783</id><entry>2020-11-30</entry><title>Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes</title><swanseaauthors><author><sid>4fea3e19b39712dea1d051d317614572</sid><firstname>Olivia</firstname><surname>McCarthy</surname><name>Olivia McCarthy</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>3fd2ee8d0217f8487c472f52ba7c6b0a</sid><firstname>Rachel</firstname><surname>Deere</surname><name>Rachel Deere</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>0103027605e3ccd2909f4170d9d2c96f</sid><firstname>Jason</firstname><surname>Pitt</surname><name>Jason Pitt</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>d7cdcf463ff032a37945843a10cad627</sid><firstname>Benjamin</firstname><surname>Wellman</surname><name>Benjamin Wellman</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>f5da81cd18adfdedb2ccb845bddc12f7</sid><ORCID>0000-0002-6986-6449</ORCID><firstname>Richard</firstname><surname>Bracken</surname><name>Richard Bracken</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-11-30</date><deptcode>STSC</deptcode><abstract>Aim: To explore the influence of clinical exercise trial participation on glycaemia and insulin therapy use in adults with type 1 diabetes (T1D). Research Design and Methods: This study involved a secondary analysis of data collected from 16 individuals with T1D who completed a randomized clinical trial consisting of 23-h in-patient phases with a 45-min evening bout of moderate intensity continuous exercise. Participants were switched from their usual basal-bolus therapy to ultra-long acting insulin degludec and rapid-acting insulin aspart as well as provided with unblinded interstitial flash-glucose monitoring systems. To assess the impact of clinical trial participation, weekly data obtained at the screening visit (pre-study involvement) were compared against those collated on the last experimental visit (post-study involvement). Interstitial glucose [iG] data were split into distinct glycaemic ranges and stratified into day (06:00–23:59) and night (00:00–05:59) time periods. A p-value of ≤ 0.05 was accepted for significance. Results: Following study completion, there were significant decreases in both the mean nocturnal iG concentration (Δ-0.9 ± 4.5 mmol.L−1, p < 0.001) and the time spent in severe hyperglycaemia (Δ-7.2 ± 9.8%, p = 0.028) during the night-time period. The total daily (Δ-7.3 ± 8.4 IU, p = 0.003) and basal only (Δ-2.3 ± 3.8 IU, p = 0.033) insulin dose requirements were reduced over the course of study involvement. Conclusions: Participation in clinical research may foster improved nocturnal glycaemia and reduced insulin therapy use in people with T1D. Recognition of these outcomes may help encourage volunteers to partake in clinical research opportunities for improved diabetes-related health outcomes. Clinical Trial Registration: DRKS.de; DRKS00013509.</abstract><type>Journal Article</type><journal>Frontiers in Public Health</journal><volume>8</volume><journalNumber/><paginationStart/><paginationEnd/><publisher>Frontiers Media SA</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>2296-2565</issnElectronic><keywords>type 1 diabetes (T1D), exercise, insulin, glycaemia, research participant experience</keywords><publishedDay>7</publishedDay><publishedMonth>1</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-01-07</publishedDate><doi>10.3389/fpubh.2020.568832</doi><url/><notes/><college>COLLEGE NANME</college><department>Sport and Exercise Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>STSC</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2021-02-02T09:14:13.5451006</lastEdited><Created>2020-11-30T09:30:11.4841424</Created><path><level id="1">Faculty of Science and Engineering</level><level id="2">School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences</level></path><authors><author><firstname>Olivia</firstname><surname>McCarthy</surname><order>1</order></author><author><firstname>Rachel</firstname><surname>Deere</surname><order>2</order></author><author><firstname>Max L.</firstname><surname>Eckstein</surname><order>3</order></author><author><firstname>Jason</firstname><surname>Pitt</surname><order>4</order></author><author><firstname>Benjamin</firstname><surname>Wellman</surname><order>5</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>6</order></author><author><firstname>Othmar</firstname><surname>Moser</surname><order>7</order></author><author><firstname>Richard</firstname><surname>Bracken</surname><orcid>0000-0002-6986-6449</orcid><order>8</order></author></authors><documents><document><filename>55783__19060__50163f8521de4604b37b0bb489e4ea35.pdf</filename><originalFilename>55783.pdf</originalFilename><uploaded>2021-01-14T13:16:10.9955805</uploaded><type>Output</type><contentLength>548621</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2021 McCarthy, Deere, Eckstein, Pitt, Wellman, Bain, Moser and Bracken. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY)</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2021-02-02T09:14:13.5451006 v2 55783 2020-11-30 Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes 4fea3e19b39712dea1d051d317614572 Olivia McCarthy Olivia McCarthy true false 3fd2ee8d0217f8487c472f52ba7c6b0a Rachel Deere Rachel Deere true false 0103027605e3ccd2909f4170d9d2c96f Jason Pitt Jason Pitt true false d7cdcf463ff032a37945843a10cad627 Benjamin Wellman Benjamin Wellman true false 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false f5da81cd18adfdedb2ccb845bddc12f7 0000-0002-6986-6449 Richard Bracken Richard Bracken true false 2020-11-30 STSC Aim: To explore the influence of clinical exercise trial participation on glycaemia and insulin therapy use in adults with type 1 diabetes (T1D). Research Design and Methods: This study involved a secondary analysis of data collected from 16 individuals with T1D who completed a randomized clinical trial consisting of 23-h in-patient phases with a 45-min evening bout of moderate intensity continuous exercise. Participants were switched from their usual basal-bolus therapy to ultra-long acting insulin degludec and rapid-acting insulin aspart as well as provided with unblinded interstitial flash-glucose monitoring systems. To assess the impact of clinical trial participation, weekly data obtained at the screening visit (pre-study involvement) were compared against those collated on the last experimental visit (post-study involvement). Interstitial glucose [iG] data were split into distinct glycaemic ranges and stratified into day (06:00–23:59) and night (00:00–05:59) time periods. A p-value of ≤ 0.05 was accepted for significance. Results: Following study completion, there were significant decreases in both the mean nocturnal iG concentration (Δ-0.9 ± 4.5 mmol.L−1, p < 0.001) and the time spent in severe hyperglycaemia (Δ-7.2 ± 9.8%, p = 0.028) during the night-time period. The total daily (Δ-7.3 ± 8.4 IU, p = 0.003) and basal only (Δ-2.3 ± 3.8 IU, p = 0.033) insulin dose requirements were reduced over the course of study involvement. Conclusions: Participation in clinical research may foster improved nocturnal glycaemia and reduced insulin therapy use in people with T1D. Recognition of these outcomes may help encourage volunteers to partake in clinical research opportunities for improved diabetes-related health outcomes. Clinical Trial Registration: DRKS.de; DRKS00013509. Journal Article Frontiers in Public Health 8 Frontiers Media SA 2296-2565 type 1 diabetes (T1D), exercise, insulin, glycaemia, research participant experience 7 1 2021 2021-01-07 10.3389/fpubh.2020.568832 COLLEGE NANME Sport and Exercise Sciences COLLEGE CODE STSC Swansea University 2021-02-02T09:14:13.5451006 2020-11-30T09:30:11.4841424 Faculty of Science and Engineering School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences Olivia McCarthy 1 Rachel Deere 2 Max L. Eckstein 3 Jason Pitt 4 Benjamin Wellman 5 Steve Bain 0000-0001-8519-4964 6 Othmar Moser 7 Richard Bracken 0000-0002-6986-6449 8 55783__19060__50163f8521de4604b37b0bb489e4ea35.pdf 55783.pdf 2021-01-14T13:16:10.9955805 Output 548621 application/pdf Version of Record true © 2021 McCarthy, Deere, Eckstein, Pitt, Wellman, Bain, Moser and Bracken. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) true eng http://creativecommons.org/licenses/by/4.0/ |
title |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes |
spellingShingle |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes Olivia McCarthy Rachel Deere Jason Pitt Benjamin Wellman Steve Bain Richard Bracken |
title_short |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes |
title_full |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes |
title_fullStr |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes |
title_full_unstemmed |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes |
title_sort |
Improved Nocturnal Glycaemia and Reduced Insulin Use Following Clinical Exercise Trial Participation in Individuals With Type 1 Diabetes |
author_id_str_mv |
4fea3e19b39712dea1d051d317614572 3fd2ee8d0217f8487c472f52ba7c6b0a 0103027605e3ccd2909f4170d9d2c96f d7cdcf463ff032a37945843a10cad627 5399f4c6e6a70f3608a084ddb938511a f5da81cd18adfdedb2ccb845bddc12f7 |
author_id_fullname_str_mv |
4fea3e19b39712dea1d051d317614572_***_Olivia McCarthy 3fd2ee8d0217f8487c472f52ba7c6b0a_***_Rachel Deere 0103027605e3ccd2909f4170d9d2c96f_***_Jason Pitt d7cdcf463ff032a37945843a10cad627_***_Benjamin Wellman 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain f5da81cd18adfdedb2ccb845bddc12f7_***_Richard Bracken |
author |
Olivia McCarthy Rachel Deere Jason Pitt Benjamin Wellman Steve Bain Richard Bracken |
author2 |
Olivia McCarthy Rachel Deere Max L. Eckstein Jason Pitt Benjamin Wellman Steve Bain Othmar Moser Richard Bracken |
format |
Journal article |
container_title |
Frontiers in Public Health |
container_volume |
8 |
publishDate |
2021 |
institution |
Swansea University |
issn |
2296-2565 |
doi_str_mv |
10.3389/fpubh.2020.568832 |
publisher |
Frontiers Media SA |
college_str |
Faculty of Science and Engineering |
hierarchytype |
|
hierarchy_top_id |
facultyofscienceandengineering |
hierarchy_top_title |
Faculty of Science and Engineering |
hierarchy_parent_id |
facultyofscienceandengineering |
hierarchy_parent_title |
Faculty of Science and Engineering |
department_str |
School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences{{{_:::_}}}Faculty of Science and Engineering{{{_:::_}}}School of Aerospace, Civil, Electrical, General and Mechanical Engineering - Sport and Exercise Sciences |
document_store_str |
1 |
active_str |
0 |
description |
Aim: To explore the influence of clinical exercise trial participation on glycaemia and insulin therapy use in adults with type 1 diabetes (T1D). Research Design and Methods: This study involved a secondary analysis of data collected from 16 individuals with T1D who completed a randomized clinical trial consisting of 23-h in-patient phases with a 45-min evening bout of moderate intensity continuous exercise. Participants were switched from their usual basal-bolus therapy to ultra-long acting insulin degludec and rapid-acting insulin aspart as well as provided with unblinded interstitial flash-glucose monitoring systems. To assess the impact of clinical trial participation, weekly data obtained at the screening visit (pre-study involvement) were compared against those collated on the last experimental visit (post-study involvement). Interstitial glucose [iG] data were split into distinct glycaemic ranges and stratified into day (06:00–23:59) and night (00:00–05:59) time periods. A p-value of ≤ 0.05 was accepted for significance. Results: Following study completion, there were significant decreases in both the mean nocturnal iG concentration (Δ-0.9 ± 4.5 mmol.L−1, p < 0.001) and the time spent in severe hyperglycaemia (Δ-7.2 ± 9.8%, p = 0.028) during the night-time period. The total daily (Δ-7.3 ± 8.4 IU, p = 0.003) and basal only (Δ-2.3 ± 3.8 IU, p = 0.033) insulin dose requirements were reduced over the course of study involvement. Conclusions: Participation in clinical research may foster improved nocturnal glycaemia and reduced insulin therapy use in people with T1D. Recognition of these outcomes may help encourage volunteers to partake in clinical research opportunities for improved diabetes-related health outcomes. Clinical Trial Registration: DRKS.de; DRKS00013509. |
published_date |
2021-01-07T04:10:15Z |
_version_ |
1763753711626092544 |
score |
11.037603 |